16th February 2021
- 0 comments
Drug discovery and development company, Blueberry Therapeutics, is announcing a £3.6m extension to its previously successful £10.8m Series B fundraising.
Japanese investor, Medical Incubator Japan (MIJ), and a private syndicate of US Board Certified Dermatologists - led by Dr Omar Ibrahimi of the Connecticut Skin Institute - have invested £3.1m and £500k, respectively.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage